The global blood group typing market
size is anticipated to reach USD 3.44 billion by 2026. It is expected to expand
at a CAGR of 9.7% during the forecast period. Factors, such as rising usage of
blood group typing in forensic sciences and prenatal testing, increasing number
of blood transfusions due to number of road accidents, and growing demand for
blood and associated products are projected to drive the growth.
Access
Sample Report of this report @ https://www.radiantinsights.com/research/blood-group-typing-market/request-sample
Blood group typing determines and identifies
the O, A, B, and AB blood groups with the help of laboratory tests. The test is
mandatory before transfusion as it enables checking compatibility of the blood
types of the donor and the recipient along with determining the Rh factor.
These tests are also performed to determine Hemolytic Disease of the Newborn
(HDN) in pregnant women, which is anticipated to further drive the growth.
Consumables dominated the product
segment in 2018 and is expected to witness significant growth over the forecast
period due to the increase in surgical procedures, such as organ
transplantation. Factors, such as increasing use of serological fluids and
reagents in laboratories and high blood donation rates are anticipated to
further fuel the segment growth. North America held the largest share of the
global blood group testing market in 2018. Asia Pacific is anticipated to
register the fastest CAGR during the forecast period.
Lack of awareness, proper blood service
infrastructure, and skilled professionals, as well as the risk of transmissible
diseases such as HIV and hepatitis B are some of the factors that may impede
the growth of the market for blood group testing.
Further
key findings from the study suggest:
• PCR-based and microarray technique
segment is expected to register the fastest CAGR during the forecast period,
due to increasing R&D activities focused on antibody-antigen interactions
coupled with high prevalence of chronic diseases
• Consumables segment held the largest
market share in 2018 among the products due to increase in number of
transfusions and surgical procedures involving organ transplants
• Asia Pacific is projected to exhibit
the fastest CAGR during the forecast period, attributed to the factors such as
rising per capita healthcare expenditure, prevalence of chronic diseases, and
improving healthcare infrastructure
• Key players of operating in the blood
group typing market include Grifols, S.A.;Bio-Rad Laboratories, Inc.;Merck
KGaA; Immucor, Inc.; Novacyt Group; Danaher Corporation; Agena Bioscience,
Inc.; Ortho Clinical Diagnostics; and Quotient, Ltd
Browse
Complete Report Summary with TOC here https://www.radiantinsights.com/research/blood-group-typing-market
About
Radiant Insights
Radiant Insights is a platform for
companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure
market research reports, helping them in the decision making process. We have a
comprehensive collection of reports, covering over 40 key industries and a host
of micro markets. In addition to over extensive database of reports, our
experienced research coordinators also offer a host of ancillary services such
as, research partnerships/ tie-ups and customized research solutions.
Media
Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com
No comments:
Post a Comment